Baird Medical Investment Holdings Ltd
BDMD1.390USD
-0.020-1.42%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
36.91MMarket Cap
LossP/E TTM
More Details of Baird Medical Investment Holdings Ltd Company
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd Info
Ticker SymbolBDMD
Company nameBaird Medical Investment Holdings Ltd
IPO dateDec 13, 2021
CEOWu (Haimei)
Number of employees143
Security typeOrdinary Share
Fiscal year-endDec 13
Address18/F, Ovest
CityGUANGZHOU
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code- -
Phone
Websitehttps://ir.bairdmed.com/
Ticker SymbolBDMD
IPO dateDec 13, 2021
CEOWu (Haimei)
Company Executives of Baird Medical Investment Holdings Ltd
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Mr. Jin Xu
Mr. Jin Xu
Quality Assurance Department Manager
Quality Assurance Department Manager
--
--
Mr. Wei Xu
Mr. Wei Xu
Merchandising Department Manager
Merchandising Department Manager
--
--
Mr. Robin Yang
Mr. Robin Yang
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
37.04M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Shareholding Stats
Updated: Thu, Nov 20
Updated: Thu, Nov 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Shareholders
Shareholders
Proportion
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Shareholder Types
Shareholders
Proportion
Individual Investor
71.59%
Corporation
28.32%
Investment Advisor/Hedge Fund
0.78%
Hedge Fund
0.67%
Investment Advisor
0.32%
Research Firm
0.05%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
34
465.80K
9.90%
--
2025Q3
47
465.80K
18.84%
-72.37K
2025Q2
50
538.17K
21.64%
+180.74K
2025Q1
80
357.43K
67.10%
-16.79M
2024Q4
85
305.49K
75.32%
+42.45K
2024Q3
88
263.04K
299.72%
-979.92K
2024Q2
90
1.24M
285.03%
-389.76K
2024Q1
94
1.63M
272.11%
-20.00M
2023Q4
94
1.73M
289.40%
-2.99M
2023Q3
93
4.71M
469.75%
-226.48K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wu (Haimei)
18.30M
71.59%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
18.68%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.65%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.49%
--
--
Jun 30, 2025
Highbridge Capital Management, LLC
125.00K
0.49%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
91.45K
0.36%
+34.51K
+60.61%
Jun 30, 2025
Northern Trust Investments, Inc.
52.44K
0.21%
+52.44K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
25.44K
0.1%
+9.51K
+59.70%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Baird Medical Investment Holdings Ltd?
The top five shareholders of Baird Medical Investment Holdings Ltd are:
Wu (Haimei) holds 18.30M shares, accounting for 71.59% of the total shares.
ExcelFin SPAC LLC holds 4.77M shares, accounting for 18.68% of the total shares.
Grand Fortune Capital (H.K.) Co, Ltd. holds 2.46M shares, accounting for 9.65% of the total shares.
Periscope Capital holds 125.00K shares, accounting for 0.49% of the total shares.
Highbridge Capital Management, LLC holds 125.00K shares, accounting for 0.49% of the total shares.
Wu (Haimei) holds 18.30M shares, accounting for 71.59% of the total shares.
ExcelFin SPAC LLC holds 4.77M shares, accounting for 18.68% of the total shares.
Grand Fortune Capital (H.K.) Co, Ltd. holds 2.46M shares, accounting for 9.65% of the total shares.
Periscope Capital holds 125.00K shares, accounting for 0.49% of the total shares.
Highbridge Capital Management, LLC holds 125.00K shares, accounting for 0.49% of the total shares.
What are the top three shareholder types of Baird Medical Investment Holdings Ltd?
The top three shareholder types of Baird Medical Investment Holdings Ltd are:
Wu (Haimei)
ExcelFin SPAC LLC
Grand Fortune Capital (H.K.) Co, Ltd.
Wu (Haimei)
ExcelFin SPAC LLC
Grand Fortune Capital (H.K.) Co, Ltd.
How many institutions hold shares of Baird Medical Investment Holdings Ltd (BDMD)?
As of 2025Q4, 34 institutions hold shares of Baird Medical Investment Holdings Ltd, with a combined market value of approximately 465.80K, accounting for 9.90% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -8.94%.
What is the biggest source of revenue for Baird Medical Investment Holdings Ltd?
In FY2024, the MWA Needles business generated the highest revenue for Baird Medical Investment Holdings Ltd, amounting to 33.83M and accounting for 91.33% of total revenue.
